Confronting Pancreatic Cancer

Pancreas Cancer News Center

Pancreatic Cancer News and Archives

For access to the Select Abstractssm section, please click here

For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer

Search our News and Archives

Keyword(s) to Search:
Options:

Browse by Quarter

2009 | 1st Quarter | 2nd Quarter

2008 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2007 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2006 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2005 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2004 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2003 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2002 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2001 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2000 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2009 Third Quarter

Norepinephrine-Induced Invasion by Pancreatic Cancer Cells is Inhibited by Propranolol
October 1, 2009
...more

Review of Adjuvant Radiochemotherapy for Resected Pancreatic Cancer and Results from Mayo Clinic for the 5th JUCTS Symposium
October 1, 2009
...more

A Dose-Finding and Pharmacodynamic Study of Bortezomib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
September 23, 2009
...more

A Matched Case-Control Study of Preoperative Biliary Drainage in Patients with Pancreatic Adenocarcinoma: Routine Drainage Is Not Justified
September 23, 2009
...more

Pancreatic Islet Cell Carcinoma Presenting with Concurrent Cushing's and Zollinger-Ellison Syndromes: Case Series and Literature Review
September 18, 2009
...more

Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative Resection
September 18, 2009
...more

Margin Positive Pancreaticoduodenectomy Is Superior to Palliative Bypass in Locally Advanced Pancreatic Ductal Adenocarcinoma
September 16, 2009
...more

Histologic Characteristics Enhance Predictive Value of American Joint Committee on Cancer Staging in Resectable Pancreas Cancer
September 15, 2009
...more

Second- and Third-line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma: Feasibility and Potential Benefits in a Retrospective Series of 117 Patients
September 14, 2009
...more

Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
September 9, 2009
...more

Pancreatic Adenocarcinoma Tumor Grade Determination Using Contrast-Enhanced Magnetic Resonance Imaging
September 8, 2009
...more

Tumor Markers in Pancreatic Cancer: A European Group on Tumor Markers (EGTM) Status Report
September 8, 2009
...more

Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment?
September 4, 2009
...more

Metastatic Pancreatic Adenocarcinoma and Renal Cell Carcinoma Treated with Gemcitabine and Sunitinib Malate. A Case Report
September 4, 2009
...more

Pancreatic Neuroendocrine Tumors Among Patients with Intraductal Papillary Mucinous Neoplasms: Real Association or Just a Coincidence?
September 4, 2009
...more

Surgical Resection after TNFerade Therapy for Locally Advanced Pancreatic Cancer
September 4, 2009
...more

Antisense Inhibition of MicroRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
September 2, 2009
...more

Classification of R1 Resections for Pancreatic Cancer: The Prognostic Relevance of Tumour Involvement within 1 mm of a Resection Margin
September 1, 2009
...more

Downstaging of Pancreatic Carcinoma after Neoadjuvant Chemoradiation
September 1, 2009
...more

Effectiveness of S-1 Therapy for Unresectable/Advanced Pancreas Cancer
September 1, 2009
...more

Genome-wide Association Study Identifies Variants in the ABO Locus Associated with Susceptibility to Pancreatic Cancer
September 1, 2009
...more

MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease
September 1, 2009
...more

Pancreatic Incidentalomas: High Rate of Potentially Malignant Tumors
September 1, 2009
...more

Pancreatic Insulinoma: A Surgical Experience
September 1, 2009
...more

Phase II Study of Bevacizumab with Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411
September 1, 2009
...more

Radiofrequency Ablation of Solitary Pancreatic Insulinoma in a Patient with Episodes of Severe Hypoglycemia
September 1, 2009
...more

Survival Analysis after Pancreatic Resection for Ampullary and Pancreatic Head Carcinoma: An Analysis of Clinicopathological Factors
August 31, 2009
...more

Cumulative Morbidity and Late Mortality in Long-Term Survivors of Exocrine Pancreas Cancer
August 29, 2009
...more

Resectable Pancreatic Cancer: Who Really Benefits from Resection?
August 26, 2009
...more

Clinical Impact of Radiotherapy for Locally Advanced Pancreatic Cancer
August 25, 2009
...more

Robotic Resection of Intraductal Neoplasm of the Pancreas
August 21, 2009
...more

Risk Factors for Sporadic Pancreatic Endocrine Tumors: A Case-Control Study of Prospectively Evaluated Patients
August 18, 2009
...more

Role of Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
August 18, 2009
...more

Pancreatic Proteolytic Enzyme Therapy Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer
August 17, 2009
...more

A Phase 2 Trial of Glufosfamide in Combination With Gemcitabine in Chemotherapy-Naive Pancreatic Adenocarcinoma
August 14, 2009
...more

A Preoperative Prognostic Score for Resected Pancreatic and Periampullary Neuroendocrine Tumours
August 14, 2009
...more

Cetuximab-Based Therapy Versus Non-Cetuximab Therapy for Advanced Cancer: A Meta-Analysis of 17 Randomized Controlled Trials
August 13, 2009
...more

Glucagon/Insulin Ratio as a Potential Biomarker for Pancreatic Cancer in Patients with New-onset Diabetes Mellitus
August 13, 2009
...more

Pancreatic Endocrine Tumors: A Large Single-Center Experience
August 6, 2009
...more

Diagnosis and Treatment of Pancreatic Vasoactive Intestinal Peptide Endocrine Tumors
August 5, 2009
...more

A Fuller Understanding of Pancreatic Neuroendocrine Tumours Combined with Aggressive Management Improves Outcome
August 4, 2009
...more

Multidetector CT Evaluation of the Course of Nonresectable Pancreatic Carcinomas with Neoadjuvant Therapy
August 4, 2009
...more

Can Preoperative CA19-9 and CEA Levels Predict the Resectability of Patients with Pancreatic Adenocarcinoma?
August 3, 2009
...more

Management of Advanced Neuroendocrine Tumors with Hepatic Metastasis
August 3, 2009
...more

Clinical Overview on Lipoplatin: A Successful Liposomal Formulation of Cisplatin
August 1, 2009
...more

Gemcitabine Combined with Uracil-Tegafur in Patients with Advanced Pancreatic Cancer
August 1, 2009
...more

Patient and Hospital Characteristics on the Variance of Perioperative Outcomes for Pancreatic Resection in the United States: A Plea for Outcome-Based and not Volume-Based Referral Guidelines
August 1, 2009
...more

Preclinical and Clinical Aspects of Carboplatin and Gemcitabine Combined with Whole-Body Hyperthermia for Pancreatic Adenocarcinoma
August 1, 2009
...more

Prognostic Factors for Survival after Extended Pancreatectomy for Pancreatic Head Cancer: Influence of Resection Margin Status on Survival
August 1, 2009
...more

Adjuvant Chemoradiotherapy after Pancreatic Resection for Invasive Carcinoma Associated with Intraductal Papillary Mucinous Neoplasm of the Pancreas
July 31, 2009
...more

Detection of Unknown Primary Neuroendocrine Tumours (CUP-NET) using (68)Ga-DOTA-NOC Receptor PET/CT
July 18, 2009
...more

Phase I Study of Fixed Dose Gemcitabine Plus Epirubicin in Patients with Advanced Solid Malignancies
July 10, 2009
...more

Identification of Human Pancreatic Cancer Stem Cells
July 7, 2009
...more

Pancreatic Cancer--Could it Be That Simple? A Different Context of Vulnerability
July 7, 2009
...more

Prognostic Factors and Adjuvant Chemoradiation Therapy After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
July 7, 2009
...more

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients with Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
July 6, 2009
...more

Sirolimus Can Reverse Resistance to Gemcitabine, Capecitabine and Docetaxel Combination Therapy in Pancreatic Cancer
July 6, 2009
...more

A Multicenter Phase II Study of Gemcitabine and S-1 Combination Chemotherapy in Patients with Unresectable Pancreatic Cancer
July 4, 2009
...more

A Resected Case of Effective Treatment with S-1/Gemcitabine and Paclitaxel Combination Chemotherapy for Advanced Pancreatic Cancer with Peritoneal and Liver Metastases
July 1, 2009
...more

Antitumor Activity of Gemcitabine and Oxaliplatin is Augmented by Thymoquinone in Pancreatic Cancer
July 1, 2009
...more

Continuous Treatment with S-1, an Effective Strategy for an Older Adult with Unresectable Advanced Pancreatic Cancer with Peritoneal Dissemination-A Case Report
July 1, 2009
...more

CEACAM1 Expression in Pancreatic Endocrine Tumors
July 1, 2009
...more

Curcumin Analogues Exhibit Enhanced Growth Suppressive Activity in Human Pancreatic Cancer Cells
July 1, 2009
...more

Feasibility and Efficacy of Combination Therapy with Preoperative Full-dose Gemcitabine, Concurrent Three-dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer
July 1, 2009
...more

Gemcitabine-Based Chemogene Therapy for Pancreatic Cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA Strategies
July 1, 2009
...more

Multivisceral Resection for Pancreatic Malignancies: Risk-analysis and Long-term Outcome
July 1, 2009
...more

Neoadjuvant Chemoradiation and Pancreaticoduodenectomy for Initially Locally Advanced Head Pancreatic Adenocarcinoma
July 1, 2009
...more

Pancreatic Adenocarcinoma in a Young Patient Population--12-year Experience at Memorial Sloan Kettering Cancer Center
July 1, 2009
...more

Polyethylene Glycosylated Curcumin Conjugate Inhibits Pancreatic Cancer Cell Growth Through Inactivation of Jab1
July 1, 2009
...more

Safety of Chronic Low-Dose Capecitabine as MaintenanceTherapy in Gastrointestinal Cancers
July 1, 2009
...more

Saline-linked Surface Radiofrequency Ablation: A Safe and Effective Method of Surface Ablation of Hepatic Metastatic Colorectal Cancer
July 1, 2009
...more

Survival after Pancreaticoduodenectomy is not Improved by Extending Resections to Achieve Negative Margins
July 1, 2009
...more

Systematic Review and Meta-analysis of Prophylactic Gastroenterostomy for Unresectable Advanced Pancreatic Cancer
July 1, 2009
...more

2009
2nd Quarter
1st Quarter

2008
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2007
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2006
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2005
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2004
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2003
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2002
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2001
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2000
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

For educational purposes only; not to be relied upon
Please read Pancreatica Disclaimer

Home | In The News | Links | Donations
FAQ | Clinical Trials Registry | Research Resources | About Us

webmaster

©2000-2010 Pancreatica.org - All Rights Reserved
www.pancreatica.org